A tighter archive for life-science signals.
Search once, then narrow by source or topic.
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 - Nasdaq
10x Genomics (TXG) Price Target Increased by 10.47% to 16.66 Nasdaq
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump - simplywall.st
There's Reason For Concern Over 10x Genomics, Inc.'s (NASDAQ:TXG) Massive 42% Price Jump simplywall.st
10x Genomics (NASDAQ:TXG) Nasdaq Futures Drives Data Biology - Kalkine Media
10x Genomics (NASDAQ:TXG) Nasdaq Futures Drives Data Biology Kalkine Media
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
Piper Sandler Maintains 10x Genomics (TXG) Neutral Recommendation Nasdaq
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript Insider Monkey
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation Nasdaq
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% Markets Financial Content
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates Nasdaq
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Nasdaq
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics Nasdaq
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results Stock Titan
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Yahoo Finance
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% Yahoo Finance
10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates - Nasdaq
10x Genomics (TXG) Surpasses Q2 Earnings and Revenue Estimates Nasdaq
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page